TRUNCATED HUMAN P450 2D6 - EXPRESSION IN ESCHERICHIA-COLI, NI2+-CHELATE AFFINITY PURIFICATION, AND CHARACTERIZATION OF SOLUBILITY AND AGGREGATION

被引:51
作者
KEMPF, AC
ZANGER, UM
MEYER, UA
机构
[1] UNIV BASEL, BIOZENTRUM, DEPT PHARMACOL, CH-4056 BASEL, SWITZERLAND
[2] DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL, D-70376 STUTTGART, GERMANY
关键词
CYTOCHROME P450 2D6; HETEROLOGOUS EXPRESSION IN ESCHERICHIA-COLI; NI2+-CHELATE AFFINITY CHROMATOGRAPHY; ANALYTICAL ULTRACENTRIFUGATION;
D O I
10.1006/abbi.1995.1396
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 2D6 is one of the clinically important drug-oxidizing enzymes in human liver. We constructed an Escherichia coli expression vector to obtain large amounts of this microsomal hemoprotein in a form suitable for purification and further structural analysis. The N-terminal 25 amino acids, which presumably serve as a membrane anchor, were replaced by codons for a [His](6) tag to increase solubility and to allow for rapid purification by Ni2+-chelate affinity chromatography. P450 2D6 apoprotein was synthesized under practically all growth conditions, whereas formation of heme-containing holoenzyme strictly depended on addition of the heme precursor delta-aminolevulinic acid to the E. coli culture. The truncated P450 was purified from the soluble cytosolic fraction to electrophoretic homogeneity (7 nmol of P450/mg protein) by affinity chromatography on Ni2+ -nitrilotriacetate-agarose. The purified protein exhibited a CO-reduced difference spectrum with a delta(max) at 450 nm and no detectable P420. Kinetic analysis revealed a K-m value for bufuralol 1'-hydroxylation similar to the K-m of the native full-length enzyme purified from human liver microsomes. To characterize the purified truncated protein with respect to hydrodynamic properties, we performed sedimentation velocity and sedimentation equilibrium analysis, These studies demonstrated that approximately 50% of the protein was in a highly aggregated state, Another 30% consisted of a single protein species with an approximated molecular weight of 200,000 and the residual 20% represented at least two other species with lower molecular weights. To prevent formation of such unexpectedly high aggregation states, purification was also performed in the presence of ''nonaethyleneglycol monododecyl ether'' (C(12)E(9)), a nonionic, chemically defined detergent often used in attempts to crystallize membrane proteins. Over 80% of this preparation was found to consist of a single protein species with a M(r) of 62,000 indicating a monomeric state, These data demonstrate that (i) N-terminal truncation of P450 2D6 does not principally interfere with heme incorporation and function of the enzyme, (ii) deletion of the hydrophobic N-terminus leads to a protein product which can be recovered largely from the soluble E. coli fraction, and (iii) this soluble truncated protein is highly aggregated unless detergents are added to maintain it in a monomeric state. (C) 1995 Academic Press, Inc.
引用
收藏
页码:277 / 288
页数:12
相关论文
共 62 条
[1]   EXPRESSION AND ENZYMATIC-ACTIVITY OF RECOMBINANT CYTOCHROME-P450 17-ALPHA-HYDROXYLASE IN ESCHERICHIA-COLI [J].
BARNES, HJ ;
ARLOTTO, MP ;
WATERMAN, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (13) :5597-5601
[2]  
BROWN CA, 1989, J BIOL CHEM, V264, P4442
[3]  
BUJARD H, 1987, METHOD ENZYMOL, V155, P416
[4]   AN ALL-SPEED AUTOCALIBRATION METHOD FOR SEDIMENTATION EQUILIBRIUM IN DILUTE HOMOGENEOUS AND MULTICOMPONENT SOLUTIONS .2. DETERMINATION OF MOLECULAR-WEIGHTS OF PROTEINS [J].
CHERNYAK, VY ;
MAGRETOVA, NN ;
DRACHEV, VA .
ANALYTICAL BIOCHEMISTRY, 1982, 123 (01) :110-119
[5]   CYTOCHROME-P450 - PROGRESS AND PREDICTIONS [J].
COON, MJ ;
DING, XX ;
PERNECKY, SJ ;
VAZ, ADN .
FASEB JOURNAL, 1992, 6 (02) :669-673
[6]   DETERMINATION OF THE MEMBRANE TOPOLOGY OF THE PHENOBARBITAL-INDUCIBLE RAT-LIVER CYTOCHROME-P-450 ISOENZYME PB-4 USING SITE-SPECIFIC ANTIBODIES [J].
DELEMOSCHIARANDINI, C ;
FREY, AB ;
SABATINI, DD ;
KREIBICH, G .
JOURNAL OF CELL BIOLOGY, 1987, 104 (02) :209-219
[7]   THE GENETIC-POLYMORPHISM OF DEBRISOQUINE SPARTEINE METABOLISM - CLINICAL ASPECTS [J].
EICHELBAUM, M ;
GROSS, AS .
PHARMACOLOGY & THERAPEUTICS, 1990, 46 (03) :377-394
[8]   HIGH-LEVEL EXPRESSION OF FUNCTIONAL HUMAN CYTOCHROME-P450 1A2 IN ESCHERICHIA-COLI [J].
FISHER, CW ;
CAUDLE, DL ;
MARTINWIXTROM, C ;
QUATTROCHI, LC ;
TUKEY, RH ;
WATERMAN, MR ;
ESTABROOK, RW .
FASEB JOURNAL, 1992, 6 (02) :759-764
[9]  
GARDNER LC, 1991, J BIOL CHEM, V266, P22010
[10]   EXPRESSION OF MODIFIED HUMAN CYTOCHROME-P450 3A4 IN ESCHERICHIA-COLI AND PURIFICATION AND RECONSTITUTION OF THE ENZYME [J].
GILLAM, EMJ ;
BABA, T ;
KIM, BR ;
OHMORI, S ;
GUENGERICH, FP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 305 (01) :123-131